Cargando…

The prevalence of diabetes distress among patients with type 2 diabetes in Jordan

OBJECTIVES: Diabetes distress (DD) is a state of emotional distress that evolves from living with chronic disease and the burden of daily adjustments of medications and lifestyle. This study investigated the prevalence of DD in patients with type 2 diabetes mellitus (T2DM) in Jordan and the related...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiasat, Duaa A., Salih, Maryam B., Abu Jaber, Aseel H., Abubaker, Obada F., Qandeel, Yousef A., Saleem, Bushra A., Aburumman, Sally I., Al-Sayyed, Abdel Rahman H., Hussein, Tariq I., Hyassat, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213091/
https://www.ncbi.nlm.nih.gov/pubmed/37250811
http://dx.doi.org/10.1016/j.jtumed.2023.04.002
Descripción
Sumario:OBJECTIVES: Diabetes distress (DD) is a state of emotional distress that evolves from living with chronic disease and the burden of daily adjustments of medications and lifestyle. This study investigated the prevalence of DD in patients with type 2 diabetes mellitus (T2DM) in Jordan and the related sociodemographic and medical factors. METHODS: We conducted a cross-sectional study in 608 patients with T2DM in Jordan, ranging from ages 15 to 80 years. The participants filled out a questionnaire where they were asked to self-assess their DD using the Diabetes Distress Scale. In all, 32 participants were excluded according to the exclusion criteria, which resulted in 576 people being included in this study. RESULTS: The overall prevalence of DD was 53% (25% had moderate distress and 28% had high distress). Emotional distress had the highest prevalence among the DD subscales, with a total prevalence of 58.8%. The data showed a significant association of DD with different factors including age, the presence of diabetic complications, the type of medication used, and medication adherence. CONCLUSION: This study showed a high prevalence of DD (53%). This finding should raise awareness to healthcare providers about the importance of screening for DD as part of the treatment guidelines, especially in patients who are on multiple medication regimens for DM; patients who have previous medical complications related to DM; and those who exhibit poor adherence to medications, which was found to be a risk factor of DD in this study.